Severe asthma: more finesse required on oral corticosteroids

For all the excitement about monoclonal antibodies in the management of severe asthma, oral corticosteroids are here to stay for the foreseeable future, leading respiratory physicians say. And this means there needs to be more work on how to better titrate doses of corticosteroids and evidence-based guidance on how to safely and effectively reduce or ...